There are four main kinds of leukemia: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). Doctors sort them along two axes — how fast the cells grow (acute versus chronic) and which cell line went rogue (lymphoid versus myeloid). That two-by-two grid drives everything that follows: how sick you feel, how urgently you need treatment, and what your odds look like.
The practical difference matters enormously. Acute leukemias fill the marrow with immature blast cells in weeks and require treatment within days of diagnosis. Chronic leukemias can simmer for years — some CLL patients are simply monitored and never treated at all. Below, I’ll walk through each type the way I explain it in clinic, plus the rarer variants most articles skip.
The Four Main Kinds of Leukemia at a Glance
| Type | Cell line | Speed | Who gets it | Typical 5-year survival |
|---|---|---|---|---|
| ALL (acute lymphoblastic) | Lymphoid | Acute | Peak ages 2–5; second peak over 50 | ~90% in children, ~40% in adults |
| AML (acute myeloid) | Myeloid | Acute | Median age ~68 | ~30% overall; higher under 60 |
| CLL (chronic lymphocytic) | Lymphoid | Chronic | Median age ~70; rare under 40 | ~87% |
| CML (chronic myeloid) | Myeloid | Chronic | Median age ~65 | ~70%+; near-normal lifespan on modern drugs |
Acute Lymphoblastic Leukemia (ALL)
ALL is the most common childhood cancer and the type most people picture when they hear “leukemia.” Immature lymphoblasts crowd out normal marrow within weeks, producing anemia, low platelets, and neutropenia all at once.
Most cases are B-cell in origin. If you or your child has been given that label, our detailed guide to B-cell ALL survival rates and treatment strategies covers the subtypes in depth. Treatment runs 2–3 years in phases: induction, consolidation, and maintenance, with central nervous system prophylaxis because blasts hide in the spinal fluid.
Acute Myeloid Leukemia (AML)
AML arises from myeloid precursors — the cells that should become neutrophils, red cells, and platelets. It’s the most common acute leukemia in adults and the most aggressive of the four.
Diagnosis requires 20% or more blasts in blood or marrow (or specific genetic abnormalities regardless of blast count). One subtype, acute promyelocytic leukemia (APL), is a genuine emergency because of catastrophic bleeding risk — but it’s also the most curable, with cure rates above 90% using ATRA and arsenic trioxide rather than standard chemo.
Chronic Lymphocytic Leukemia (CLL)
CLL is the most common leukemia in Western adults, and it’s often found by accident. A routine CBC shows a lymphocyte count of 20,000 or 40,000 in someone who feels perfectly fine. Diagnosis requires a sustained monoclonal B-lymphocyte count of at least 5,000/µL.
Roughly a third of patients never need treatment. We call this “watch and wait,” and it frustrates patients enormously — but multiple trials confirm that treating early-stage, asymptomatic CLL doesn’t extend life. Treatment starts when there’s progressive marrow failure, bulky nodes, massive splenomegaly, or rapid lymphocyte doubling.
Chronic Myeloid Leukemia (CML)
CML is the great success story of modern oncology. Nearly every case carries the Philadelphia chromosome — a swap between chromosomes 9 and 22 that creates the BCR-ABL1 fusion gene, a permanently switched-on growth signal.
Before 2001, median survival was about 5 years. Then imatinib arrived. Patients who achieve a deep molecular response on a tyrosine kinase inhibitor now have life expectancy approaching that of the general population, and some can eventually stop the drug entirely under close monitoring.
Less Common Types Worth Knowing
- Hairy cell leukemia — rare, indolent, named for the cytoplasmic projections on the malignant B cells. Exquisitely responsive to cladribine.
- Chronic myelomonocytic leukemia (CMML) — overlaps with myelodysplastic syndrome; features persistent monocytosis.
- Large granular lymphocytic (LGL) leukemia — often associated with rheumatoid arthritis and chronic neutropenia.
- Prolymphocytic leukemia — aggressive, with very high white counts and marked splenomegaly.
Symptoms: What Overlaps and What Doesn’t
All leukemias ultimately cause trouble the same way — abnormal cells crowd out normal blood production. Because healthy white and red blood cells have distinct protective roles, losing them produces a predictable triad: fatigue (anemia), infections (neutropenia), and bruising or bleeding (thrombocytopenia).
Type-specific clues do exist:
- ALL: bone and joint pain (children may refuse to walk), testicular swelling, headaches from CNS involvement
- AML: gum hypertrophy, skin nodules (leukemia cutis), DIC in APL
- CLL: painless, rubbery, symmetric lymph node enlargement; recurrent sinopulmonary infections
- CML: left upper quadrant fullness or early satiety from an enlarged spleen; night sweats
How Leukemia Is Diagnosed
It starts with a CBC and differential. A peripheral smear reviewed by a hematopathologist often narrows the field within hours — blasts point to acute disease, smudge cells to CLL, a full spectrum of maturing granulocytes to CML.
Confirmation requires marrow sampling. Because bone marrow is where all blood cells are manufactured, an aspirate and biopsy from the posterior iliac crest tells us the blast percentage, cellularity, and fibrosis. Flow cytometry, cytogenetics, and molecular testing (FISH for BCR-ABL1, NPM1 and FLT3 mutations in AML, IGHV status in CLL) then assign the exact subtype and risk group.
Several conditions mimic leukemia: infectious mononucleosis, severe infection with a leukemoid reaction, myelodysplastic syndromes, and lymphoma in the marrow. A broader overview of blood disorders for patients and caregivers is useful if your workup is still open-ended.
Causes and Risk Factors
Most patients have no identifiable cause, and nothing they did brought it on. Established risk factors include:
- Ionizing radiation exposure (therapeutic or accidental)
- Benzene and certain solvents — historically petrochemical and rubber industries
- Prior chemotherapy, especially alkylating agents and topoisomerase II inhibitors
- Tobacco smoking (raises AML risk)
- Down syndrome, Fanconi anemia, Li-Fraumeni syndrome, and other genetic conditions
- Pre-existing MDS or myeloproliferative neoplasms
Our review of practical leukemia prevention strategies focuses on the modifiable items. For context on how far treatment has come, the history of leukemia makes sobering and hopeful reading.
Treatment by Type
| Type | First-line approach | Transplant role |
|---|---|---|
| ALL | Multi-agent chemo (2–3 yrs) ± TKI if Ph-positive; CAR-T for relapse | High-risk or relapsed disease |
| AML | Intensive induction (“7+3”) or azacitidine + venetoclax if unfit | Common for intermediate/adverse risk |
| CLL | BTK inhibitors or venetoclax + obinutuzumab; watch-and-wait early on | Rare, reserved for refractory cases |
| CML | Tyrosine kinase inhibitor (imatinib, dasatinib, nilotinib) | Only if TKIs fail or blast crisis |
When to See a Doctor
Book an appointment and ask specifically for a CBC with differential if you have:
- Fatigue that’s worsened steadily over weeks and isn’t explained by sleep or stress
- Unexplained bruising, petechiae (pinpoint red dots), or gum bleeding
- Drenching night sweats or unintentional weight loss over 10% of body weight
- Painless lymph nodes larger than 1 cm persisting beyond 4 weeks
- Recurrent infections requiring repeated antibiotics
Go to the emergency department for fever above 38.3°C with known neutropenia, uncontrolled bleeding, or new confusion and shortness of breath with a very high white count.
FAQ
Which type of leukemia is the most dangerous?
AML has the lowest overall survival, largely because it strikes older adults who can’t tolerate intensive chemotherapy. Acute promyelocytic leukemia is the most immediately life-threatening in the first 48 hours due to bleeding, yet paradoxically the most curable.
Can chronic leukemia turn into acute leukemia?
Yes. CML can progress through accelerated phase into blast crisis, which behaves like acute leukemia. CLL transforms to aggressive lymphoma (Richter transformation) in a small percentage of patients.
Is leukemia inherited?
The leukemias themselves aren’t directly inherited. Certain genetic syndromes and rare familial predisposition genes raise risk, but the vast majority of cases are sporadic somatic mutations.
What white blood cell count suggests leukemia?
There’s no single number. Counts can be sky-high (over 100,000/µL) or paradoxically low in “aleukemic” presentations. The presence of blasts on the smear matters far more than the total count.
Can you live a normal life with leukemia?
Many people do. Most CML patients on TKIs work full-time indefinitely, and many CLL patients live decades. Acute leukemia demands an intense treatment year, but survivors often return to full activity.
Key Takeaways
- Four main types: ALL, AML, CLL, CML — split by speed (acute/chronic) and cell line (lymphoid/myeloid)
- Acute types need treatment within days; chronic types may only need monitoring
- A CBC with differential plus peripheral smear is the essential first test
- Molecular subtyping now determines therapy more than the old four-category label alone
- Survival has improved dramatically, especially for CML and pediatric ALL
